Stephen Taub Two Hedge Funds Poised to Benefit From a SPAC Deal Worth $1.6 Billion Sarissa and Perceptive stands to benefit from Pear Therapeutics’ merger with Pritzker-backed blank check company. Stephen Taub June 22, 2021 Alexander Denner, CIO of Sarissa Capital Management (Andrew Harrer/Bloomberg)